SOPHiA GENETICS SA (SOPH)
- Simply Wall St.
SOPHiA GENETICS (NASDAQ:SOPH) investors are sitting on a loss of 76% if they invested a year ago
SOPHiA GENETICS SA ( NASDAQ:SOPH ) shareholders should be happy to see the share price up 30% in the last quarter. But...
- Business Wire
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
GENEVA, January 10, 2023--SOPHiA GENETICS™ (Nasdaq: SOPH), a cloud-native software company in the healthcare space, has entered an agreement with Memorial Sloan Kettering Cancer Center (MSK) to offer clinicians and researchers new solutions to expand their testing and analytical capabilities. This includes incorporating proprietary Comprehensive Genomic Panel (CGP) sequencing tests such as MSK-ACCESS®, which will be commercialized by SOPHiA GENETICS as the first comprehensive ctDNA liquid biopsy
- Business Wire
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
BOSTON & LAUSANNE, Switzerland, January 04, 2023--SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023, at 8:15 a.m. PST in San Francisco.
